IBM Emptoris Sourcing up to 10.1.3 Web UI cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in IBM Emptoris Sourcing up to 10.1.3. Impacted is an unknown function of the component Web UI. Such manipulation leads to cross site scripting. This vulnerability is traded as CVE-2017-1447. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability was found in IBM Emptoris Sourcing up to 10.1.3 and classified as problematic. Affected by this issue is an unknown code block of the component Web UI. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
IBM Emptoris Sourcing 9.5 - 10.1.3 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 128172.
The bug was discovered 07/11/2017. The weakness was shared 08/31/2017 (Website). The advisory is available at www-01.ibm.com. This vulnerability is handled as CVE-2017-1447 since 11/30/2016. The attack may be launched remotely. The requirement for exploitation is a simple authentication. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
The vulnerability was handled as a non-public zero-day exploit for at least 51 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The entries VDB-106033, VDB-106035 and VDB-106036 are related to this item. If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
11/30/2016 🔍07/11/2017 🔍
08/31/2017 🔍
08/31/2017 🔍
08/31/2017 🔍
01/10/2021 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2017-1447 (🔍)
GCVE (CVE): GCVE-0-2017-1447
GCVE (VulDB): GCVE-100-106034
X-Force: 128172
See also: 🔍
Entry
Created: 08/31/2017 22:50Updated: 01/10/2021 13:51
Changes: 08/31/2017 22:50 (52), 11/12/2019 14:01 (8), 01/10/2021 13:51 (2)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.